Thymosin Alpha 1: Complete Research Guide & Chemical Profile

Thymosin Alpha 1 (TA1) is a 28 amino acid peptide originally isolated from thymic tissue, where it plays a crucial role in immune system regulation. With the chemical formula C129H215N33O55 and a molecular weight of 3108.3 Da, this bioactive compound has garnered significant attention in immunological research.

The peptide follows the amino acid sequence Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN, featuring an acetylated N-terminus that contributes to its stability and biological activity. Also known by its synonyms TA1, Thymalfasin, and Zadaxin in research literature, Thymosin Alpha 1 represents a key component of the thymic hormone family.

Initially discovered as part of thymosin fraction 5, Thymosin Alpha 1 was first characterized in the 1970s by Dr. Allan Goldstein and his research team. The peptide is naturally produced by the thymus gland and has been extensively studied for its role in T-cell maturation and immune system modulation.

Extensive research spanning over four decades has investigated Thymosin Alpha 1's immunomodulatory properties. Early studies by Goldstein et al. (1977) demonstrated the peptide's ability to restore immune function in laboratory models with compromised T-cell activity.

A landmark study published in the Journal of Biological Response Modifiers (1981) showed that Thymosin Alpha 1 could enhance T-cell proliferation and cytokine production in laboratory settings. Subsequent research has explored its effects on various immune cell populations, including natural killer cells, dendritic cells, and regulatory T-cells.

More recent investigations have focused on the peptide's molecular mechanisms. Research published in Immunopharmacology (2003) identified specific receptor interactions and downstream signaling pathways activated by Thymosin Alpha 1 in cellular models.

Clinical research has examined Thymosin Alpha 1 in various contexts, with studies published in journals such as Clinical Immunology and Immunotherapy Research documenting its effects on immune parameters in controlled laboratory environments.

Research indicates that Thymosin Alpha 1 exerts its immunomodulatory effects through multiple molecular pathways. The peptide appears to interact with specific cell surface receptors on immune cells, initiating cascades that influence gene expression and protein synthesis.

Studies suggest that Thymosin Alpha 1 can modulate the production of various cytokines, including interleukin-2, interferon-gamma, and tumor necrosis factor-alpha. These signaling molecules play critical roles in immune cell communication and activation.

Laboratory investigations have shown that the peptide may influence T-cell differentiation by affecting transcription factors such as NF-κB and AP-1. This modulation appears to promote the development of helper T-cells and enhance their functional capacity.

Additionally, research suggests that Thymosin Alpha 1 may interact with toll-like receptors (TLRs), components of the innate immune system that recognize pathogen-associated molecular patterns. This interaction could contribute to the peptide's broad immunomodulatory effects.

Thymosin Alpha 1 exhibits specific chemical characteristics that influence its stability, solubility, and handling requirements in laboratory settings. Understanding these properties is essential for researchers working with this peptide compound.

High-quality Thymosin Alpha 1 for research applications typically maintains a purity standard of ≥98% as determined by high-performance liquid chromatography (HPLC). This purity level ensures consistent results in laboratory studies and minimizes potential interference from impurities.

Mass spectrometry analysis confirms the exact molecular weight of 3108.3 Da, while amino acid analysis verifies the correct sequence composition. These analytical methods provide comprehensive quality control for research-grade peptide preparations.

Thymosin Alpha 1 demonstrates moderate stability under appropriate storage conditions. The lyophilized peptide should be stored at -20°C or below in a dry environment, protected from light and moisture. Under these conditions, the compound typically maintains stability for 2-3 years.

Once reconstituted in sterile water or buffer solutions, the peptide exhibits a half-life of approximately 2 hours at room temperature. For extended storage of reconstituted solutions, refrigeration at 2-8°C is recommended, with aliquoting to minimize freeze-thaw cycles.

The peptide shows good solubility in aqueous solutions at physiological pH, making it suitable for various laboratory applications. However, researchers should avoid prolonged exposure to extreme pH conditions or high temperatures that could lead to degradation.

Researchers seeking high-quality Thymosin Alpha 1 can find verified vendors and third-party tested batches on ChemVerify's platform. Our comprehensive database provides detailed information about supplier reliability, batch testing results, and purity certifications.

Visit the Thymosin Alpha 1 product page at /product/thymosin-alpha-1 to access current vendor listings, compare prices, and review independent laboratory analysis reports. ChemVerify's verification process ensures that listed suppliers meet stringent quality standards for research peptides.

The platform provides transparency in peptide sourcing by offering access to certificates of analysis, purity testing data, and vendor compliance information. This comprehensive approach helps researchers make informed decisions about their peptide procurement needs.

What research applications is Thymosin Alpha 1 commonly used for?

Thymosin Alpha 1 is primarily investigated for immunological research, including studies on T-cell function, immune system modulation, and cytokine production. Researchers also explore its potential in aging studies, vaccine adjuvant research, and cellular immunity investigations.

How does Thymosin Alpha 1 differ from Thymosin Beta 4 in research applications?

While both peptides originate from thymic tissue, they have distinct research focuses. Thymosin Alpha 1 is primarily studied for immune system modulation and T-cell function, whereas Thymosin Beta 4 research concentrates on wound healing, angiogenesis, and tissue repair mechanisms.

What is the typical concentration range used in laboratory studies?

Laboratory studies typically employ Thymosin Alpha 1 concentrations ranging from 0.1 μM to 100 μM, depending on the specific research application and cell culture system. In vivo research models often use different concentration ranges based on the experimental design and endpoints.

What are the recommended reconstitution protocols for research use?

For laboratory applications, Thymosin Alpha 1 is typically reconstituted in sterile water, PBS, or appropriate buffer solutions. Gentle mixing is recommended to avoid peptide degradation, and the reconstituted solution should be used promptly or stored at appropriate temperatures.

How should researchers handle potential stability issues?

Researchers should minimize freeze-thaw cycles, protect solutions from light, and maintain appropriate pH conditions. Aliquoting reconstituted peptide into single-use portions can help preserve stability and prevent degradation during repeated access.

What analytical methods are used to verify peptide integrity in research settings?

Common analytical methods include HPLC for purity analysis, mass spectrometry for molecular weight confirmation, and amino acid analysis for sequence verification. These techniques help ensure peptide integrity throughout the research process.

Explore detailed chemical profiles and research guides for compounds discussed in this article:

• BPC-157: Complete Research Guide → /learn/bpc-157
• Epithalon: Complete Research Guide → /learn/epithalon

• Read more: RFK Jr. Signals Reversal of Peptide Ban: 14 of 19 Restricted Compounds May Return → https://www.chemverify.com/learn/rfk-jr-signals-reversal-of-peptide-ban-14-of-19-restricted-compounds-may-return
• Read more: AI-Guided High-Throughput Screening Accelerates Antimicrobial Peptide-Mimicking Polymer Discovery → https://www.chemverify.com/learn/ai-guided-antimicrobial-peptide-polymer-discovery
• Read more: Re-Engineering Insulin for Oral Delivery: Structural Modifications and Formulation Advances → https://www.chemverify.com/learn/insulin-oral-delivery-peptide-engineering
• Read more: Cyclic Lipopeptides: Biosurfactant Peptides as Next-Generation Drug Delivery Modulators → https://www.chemverify.com/learn/cyclic-lipopeptides-drug-delivery-modulators
• Read more: Microneedle-Delivered Peptide Decoy Receptors Show Promise in Psoriasis Treatment → https://www.chemverify.com/learn/microneedle-peptide-decoy-receptors-psoriasis